Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05280704 · ClinicalTrials.gov registry record · NA
Traditional Dorsal Digital Block Vs Volar Subcutaneous Digital Block
A NA study, sponsored by University of Arkansas.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT05280704: Clinical Trial NA study, sponsored by University of Arkansas.
NCT05280704 is a NA study that was terminated before completion, run by University of Arkansas. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05280704, a NA study, was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This is a prospective, randomized, double-blinded controlled trial comparing two different techniques for digital blocks. Participants will be physicians who perform digital blocks as part of their everyday duty. Each participant will undergo two digital blocks and will have the opportunity to perform a digital block on another participant. This study follows a two-period cross-over design with four groups that are defined by the sequence of treatments within each group. Participants will receive two digital blocks, one using the traditional dorsal technique and one using the volar technique. Of the two injections, one of the syringes will contain 1% lidocaine without epinephrine and the other will contain sterile normal saline. The injections will be to the index finger on each hand. The hand injected first will be up to the participant. The order in which the dorsal technique versus the volar technique is performed will be randomized. Participants will not be told one of the syringes contains normal saline. Injection pain will be measured by visual analog score and recorded after each injection. Sensation in each of the 12 zones of the finger will be recorded at each minute mark until loss of sensation in all 12 zones is achieved or 15 minutes has passed, whichever comes first.
Primary Outcome
The primary outcome is injection pain as measured by the visual analog score (VAS). The VAS for pain is a straight line with one end meaning no pain and the other end meaning the worst pain imaginable. A patient indicates a point on the line that matches the amount of pain he or she feels. Data for this outcome will be analyzed using mixed-models ANOVA with Subject as the random effect. The fixed effects in the ANOVA model will be the Technique main effect, the Agent main effect, the Technique-x
Interventions
- PROCEDURE Volar digital block with lidocaine
- PROCEDURE Volar digital block with saline
- PROCEDURE Dorsal digital block with lidocaine
- PROCEDURE Dorsal digital block with saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2023-09-20 |
| Est. Completion | 2023-09-20 |
| Phase | NA |
Why NCT05280704 stopped before completion
NCT05280704 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 4 interventions - of which Volar digital block with lidocaine is the first listed.
NCT05280704 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05280704 about?
NCT05280704 is a clinical study titled "Traditional Dorsal Digital Block Vs Volar Subcutaneous Digital Block". This is a prospective, randomized, double-blinded controlled trial comparing two different techniques for digital blocks. Participants will be physicians who perform digital blocks as part of their everyday duty. Each participant will undergo two digital blocks and will have the opportunity to perfo...
What is the current status of trial NCT05280704?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2023-09-20. Estimated completion is 2023-09-20.
What interventions are being tested in trial NCT05280704?
The interventions under investigation include: Volar digital block with lidocaine (PROCEDURE), Volar digital block with saline (PROCEDURE), Dorsal digital block with lidocaine (PROCEDURE), Dorsal digital block with saline (PROCEDURE).
Who is sponsoring clinical trial NCT05280704?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05280704's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI